The present invention provides new compounds, pharmaceutical compositions and methods for the treatment and diagnosis of Chlamydia infections. The compounds are substituted ring-fused 2-pyridones and are shown to reduce the infectivity of Chlamydia. The invention further identifies the membrane-localized hexose-phosphate permease (UhpC)of Chlamydia as drug target and provides methods for the identification and development of new anti-Chlamydia compounds
本发明提供了用于治疗和诊断沙眼感染的新化合物、药物组合物和方法。这些化合物是取代环融合的2-
吡啶酮,并且已被证明可以减少沙眼的传染性。该发明进一步确定了沙眼的膜定位己糖
磷酸透过酶(UhpC)作为药物靶标,并提供了用于识别和开发新的抗沙眼化合物的方法。